COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor

G Mjaess, A Karam, F Aoun, S Albisinni, T Roumeguère, G Mjaess, A Karam, F Aoun, S Albisinni, T Roumeguère

Abstract

COVID-19 is the pandemic that hit the world starting December 2019. Recent studies and international statistics have shown an increased prevalence, morbidity as well as mortality of this disease in male patients compared to female patients. The aim of this brief communication is to describe the pathophysiology of this sex-discrepancy, based on the infectivity mechanism of the coronavirus including the Angiotensin-Converting Enzyme 2 (ACE2), the Type II transmembrane Serine Protease (TMPRSS2), and the androgen receptor. This could help understand the susceptibility of urological patients, especially those receiving androgen deprivation therapy for prostate cancer, and testosterone replacement therapy.

Keywords: Angiotensin-Converting Enzyme 2; COVID-19; Enzyme de conversion de l’angiotensine 2; Récepteur aux androgènes; Sérine protéase transmembranaire 2; Type II Transmembrane Serine Protease; androgen receptor.

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Figures

Figure 1
Figure 1
Pathway for SARS-CoV-2 virus infection mediated by androgen activity

References

    1. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet Lond Engl. 2020;395(10223):507–513.
    1. Bahrami F., Yousefi N. Females are more anxious than males: a metacognitive perspective. Iran J Psychiatry Behav Sci. 2011;5(2):83–90.
    1. Karlberg J., Chong D.S.Y., Lai W.Y.Y. Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? Am J Epidemiol. 2004;159(3):229–231.
    1. Channappanavar R., Fett C., Mack M., Ten Eyck P.P., Meyerholz D.K., Perlman S. Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection. J Immunol Baltim Md. 1950 2017;198(10):4046–4053.
    1. Song C., Wang Y., Li W., Hu B., Chen G., Xia P. Detection of 2019 novel coronavirus in semen and testicular biopsy specimen of COVID-19 patients. medRxiv. 2020 2020.03.31.20042333.
    1. Li D., Jin M., Bao P., Zhao W., Zhang S. Clinical characteristics and results of semen tests among men with coronavirus disease 2019. JAMA Netw Open. 2020;3(5):e208292.
    1. Smith J.C., Sheltzer J.M. Cigarette smoke triggers the expansion of a subpopulation of respiratory epithelial cells that express the SARS-CoV-2 receptor ACE2. bioRxiv. 2020 2020.03.28.013672.
    1. Sama I.E., Ravera A., Santema B.T., van Goor H., Ter Maaten J.M., Cleland J.G.F. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J. 2020
    1. Jin J.-M., Bai P., He W., Wu F., Liu X.-F., Han D.-M. Gender differences in patients with COVID-19: focus on severity and mortality. Infectious Diseases (except HIV/AIDS) 2020 doi: 10.1101/2020.02.23.20026864.
    1. Lucas J.M., True L., Hawley S., Matsumura M., Morrissey C., Vessella R. The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma. J Pathol. 2008;215(2):118–125.
    1. Lin B., Ferguson C., White J.T., Wang S., Vessella R., True L.D. Prostate-localized and Androgen-regulated Expression of the Membrane-bound Serine Protease TMPRSS2. Cancer Res. 1999;59(17):4180–4184.
    1. Shen L.W., Mao H.J., Wu Y.L., Tanaka Y., Zhang W. TMPRSS2: a potential target for treatment of influenza virus and coronavirus infections. Biochimie. 2017;142:1–10.
    1. Stopsack K.H., Mucci L.A., Antonarakis E.S., Nelson P.S., Kantoff P.W. TMPRSS2 and COVID-19: serendipity or opportunity for intervention? Cancer Discov. 2020
    1. Song H., Seddighzadeh B., Cooperberg M.R., Huang F.W. Expression of ACE2, the SARS-CoV-2 Receptor, and TMPRSS2 in Prostate Epithelial Cells. Eur Urol. 2020
    1. Montopoli M., Zumerle S., Vettor R., Rugge M., Zorzi M., Catapano C.V. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532) Ann Oncol Off J Eur Soc Med Oncol. 2020

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren